TargetRx Atlas

mRNA_ID Gene Name drug_ID drug_Name Disease RNA_exp_pattern Evidence Details
ENST00000324366 PRMT5 NA NA hepatoma up-regulated predicted more...
ENST00000324366 PRMT5 NA NA non-small cell lung cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA breast cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA pancreatic cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA pancreatic cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA colorectal cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA pancreatic cancer up-regulated predicted more...
ENST00000324366 PRMT5 NA NA osteosarcoma up-regulated predicted more...
ENST00000324366 PRMT5 NA NA colorectal cancer up-regulated predicted more...
ENST00000324366 PRMT5 DB09073 Palbociclib esophagus cancer down-regulated validated more...
ENST00000324366 PRMT5 DB09073 Palbociclib pancreatic cancer down-regulated validated more...
ENST00000324366 PRMT5 DB09073 Palbociclib breast cancer down-regulated validated more...
ENST00000324366 PRMT5 DB09073 Palbociclib melanoma down-regulated validated more...
@Copyright Harbin Medical University
　The 2nd Affiliated Hospital of Harbin Medical University
　 备案号：鲁ICP备2022025566号-3